Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women.
D002582:Cervix Mucus / Q000187:drug effects; D003271:Contraceptive Agents, Female / Q000494:pharmacology; D004341:Drug Evaluation; D004343:Drug Implants; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D007986:Luteinizing Hormone / Q000652:urine; D008535:Megestrol / Q000009:adverse effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009640:Norethindrone / Q000009:adverse effects; D009644:Norgestrel / Q000009:adverse effects; D010060:Ovulation; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D013997:Time Factors
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D009644:Norgestrel; D007986:Luteinizing Hormone; D008535:Megestrol; D011276:Pregnanediol; D009640:Norethindrone